Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

What's Next For Roivant? It's Not More Publicly Traded "Vants"

Executive Summary

Roivant is focused on expanding its existing subsidiaries, building new ones and appointing top leadership teams to run them, but founder and CEO Vivek Ramaswamy has put a hold on more IPOs.

Advertisement

Related Content

Full Circle: David Hung Looks Forward To Axovant's Alzheimer's Data, Reflects On Medivation
Myovant On Path To Women’s Health Leadership, CEO Says
Myovant CEO Says Buoyant IPO Reflects High Interest In Women's Health
Axovant's IPO: Harbinger Of A Biotech Bubble?

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC099132

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel